Inhibition of HBV Infection in Mouse Model by Dual Small Interfering RNA Treatment

Hong-Bin Tang,Kai-Lang Wu,Kun Jiang,Ling Peng

DOI: https://doi.org/10.3969/j.issn.1671-7856.2009.09.001

2009-01-01

Abstract:Objective To explore the therapeutic potential of RNAi on mutation in HBV genome resulting in resistance when small interfering RNA(siRNA) is futher developed as an anti-viral drug,we express simultaneously two different 21-bp hairpin siRNA duplexes that specifically attack the HBs and HBx genes of HBV,respectively,in vivo.Methods We copied the acute HBV mice model in the study,using hydrodynamics with the mouse tail.The same technique was used to treat with interfering RNA in vivo.The antigens and DNA of HBV were determined with ELISA,Immunohistochemical staining and real-time RT-PCR.Results Dual siRNA could inhibit simultaneously the level of viral DNA and viral antigens detected in the livers and sera of the treated mice relative to control animals.Conclusion This dual siRNA system provides a more powerful tool to inhibit HBV replication in vivo.